Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress SYPR Q3 2025 Earnings Return to Profitability with EPS of 002 KODK Q1 2026 Earnings A Loss as Revenue Disappears Stock Surges on Thin Data PLMR Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Not Disclosed BG Q1 2026 Earnings Earnings Surge 103 Above Estimates as Agribusiness Strength Outpaces Expectations ICICI Bank IBN Q1 2026 Earnings Modest EPS Beat Supports Slight Stock Upswing